By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

European Commission (EC) 

Rue Joseph II
Jozef II straat 70
Brussels    B-1000  Belgium
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Medical Device






Company News
European Commission (EC) Approves EUSA Pharma’s Dinutuximab Beta For The Treatment Of Patients With High-Risk Neuroblastoma 5/10/2017 8:51:17 AM
Merck & Co. (MRK) Release: European Commission (EC) Approves KEYTRUDA (Pembrolizumab) For Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma Who Failed Autologous Stem Cell Transplant And Brentuximab Vedotin (BV), Or Who Are Transplant-Ineligible And Have Failed BV 5/5/2017 6:09:53 AM
European Commission (EC) Approves Bristol-Myers Squibb (BMY)’s Opdivo (Nivolumab) For Squamous Cell Cancer Of The Head And Neck In Adults Progressing On Or After Platinum-Based Therapy 5/1/2017 7:09:46 AM
European Commission (EC) Extends Approval For Janssen-Cilag International NV (JNJ)’s DARZALEX (Daratumumab) To Include Multiple Myeloma Patients Who Have Received At Least One Prior Therapy 4/28/2017 6:21:57 AM
Zoetis (ZTS) Receives European Commission (EC) Marketing Authorization For Cytopoint (lokivetmab) 4/27/2017 6:35:19 AM
Tesaro (TSRO) Announces Approval Of VARUBY (Oral Rolapitant Tablets) By European Commission (EC) 4/26/2017 10:27:58 AM
Amgen (AMGN) Release: European Commission (EC) Approves Amgevita (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases 3/24/2017 6:50:54 AM
Celgene (CELG) Release: REVLIMID (Lenalidomide) Approved By European Commission (EC) As Monotherapy For The Maintenance Treatment Of Patients With Newly Diagnosed Multiple Myeloma After Autologous Stem Cell Transplantation 2/24/2017 6:56:31 AM
Amgen (AMGN) Wins European Commission (EC) Approval for Repatha Single-Dose Delivery Option 2/22/2017 6:19:23 AM
Zoetis (ZTS) Receives European Commission (EC) Approval For Stronghold Plus 2/16/2017 6:54:31 AM
12345678910...
//-->